The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Alexion Pharmaceuticals
ReNeu: A pivotal phase 2b trial of mirdametinib in children and adults with neurofibromatosis type 1 (NF1)-associated symptomatic inoperable plexiform neurofibroma (PN).
 
Christopher L. Moertel
Employment - OX2 Therapeutics
Leadership - OX2 Therapeutics
Stock and Other Ownership Interests - OX2 Therapeutics
Consulting or Advisory Role - Alexion Pharmaceuticals
Patents, Royalties, Other Intellectual Property - OX2 Therapeutics
Travel, Accommodations, Expenses - Alexion Pharmaceuticals
 
Angela C. Hirbe
Honoraria - Empartners
Consulting or Advisory Role - Alexion Pharmaceuticals; AstraZeneca; Intellisphere, LLC; SpringWorks Therapeutics
Research Funding - Tango Therapeutics
Patents, Royalties, Other Intellectual Property - Boehringer Ingelheim RCV GmBH & Co KG- Licensing- T-019044 Development of a Preclinical NF1-MPNST Platform Suitable for Precision Oncology Drug Discovery and Evaluation. Royalities paid through the University; Deutsches Krebsforschungszentrum-licensing agreement for PDX cell lines. Paid through the University. (Inst)
Travel, Accommodations, Expenses - Alexion Pharmaceuticals; SpringWorks Therapeutics
 
Hans H. Shuhaiber
Research Funding - AstraZeneca (Inst); NFlection Therapeutics (Inst); Recursion Pharmaceuticals (Inst); SpringWorks Therapeutics (Inst)
Other Relationship - CTF Stipend/Fund
 
David Viskochil
Honoraria - Alexion Pharmaceuticals (Inst); SpringWorks Therapeutics (Inst)
Consulting or Advisory Role - AstraZeneca (Inst); Genzyme (Inst)
Speakers' Bureau - Alexion Pharmaceuticals (Inst); SpringWorks Therapeutics (Inst)
Research Funding - Levo Therapeutics (Inst); NFlexion Therapeutics (Inst); Soleno Therapeutics (Inst); SpringWorks Therapeutics (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Alexion Pharmaceuticals (Inst)
 
Alpa Sidhu
Research Funding - SpringWorks Therapeutics
 
Kevin J. Bielamowicz
Consulting or Advisory Role - Alexion Pharmaceuticals; SpringWorks Therapeutics; US WorldMeds; Ymabs Therapeutics Inc
Speakers' Bureau - Alexion Pharmaceuticals
 
Michael Weber
Employment - SpringWorks Therapeutics
Stock and Other Ownership Interests - SpringWorks Therapeutics
 
Jack Li
Employment - SpringWorks Therapeutics
Stock and Other Ownership Interests - SpringWorks Therapeutics
Travel, Accommodations, Expenses - SpringWorks Therapeutics
 
L. Mary Smith
Employment - SpringWorks Therapeutics
Leadership - SpringWorks Therapeutics
Stock and Other Ownership Interests - SpringWorks Therapeutics
 
Lauren Weintraub
No Relationships to Disclose
 
Rene Y. McNall-Knapp
Research Funding - AstraZeneca (Inst); Incyte (Inst); Jazz Pharmaceuticals (Inst); Pfizer (Inst); SpringWorks Therapeutics (Inst)
 
Fouad M. Hajjar
Research Funding - Incyte (Inst)
 
Nicholas K. Foreman
No Relationships to Disclose
 
Timothy R. Gershon
Research Funding - SpringWorks Therapeutics (Inst)
 
Dusica Babovic-Vuksanovic
Employment - Mayo Clinic
Consulting or Advisory Role - Alexion Pharmaceuticals
Research Funding - Alexion Pharmaceuticals; Recursion Pharmaceuticals; SpringWorks Therapeutics